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1. Introduction 
Different factors have stimulated the interest on the relationships between psychiatric 
conditions and endocrine disturbances in general and thyroid disease in particular 
(Lishman, 1998). Historically, several authors have speculated about the role of hormones 
and endocrine disorders in relation to psychiatric conditions, and important attention has 
been devoted to the role of hormones in relation to control and feedback processes in neural 
structures (Carroll et al. 1981). Psychiatric syndromes have consistently been described or 
documented in endocrine diseases (Lishman, 1998; Kathol, 2002) and may pose a real 
clinical challenge for psychiatrists working in general hospitals (liaison or psychosomatic 
psychiatrists), but the evidence in the literature to support his or her intervention is limited, 
according to modern criteria. The purpose of this chapter is primarily to review available 
data in relation to the characteristics and frequency of specific psychiatric syndromes in 
primary thyroid and parathyroid disturbances; issues of diagnosis and differential 
diagnosis; mechanisms of production of psychiatric symptomatology; and treatment issues, 
including response of psychiatric syndromes to treatment of the endocrinopathy and to 
psychotropic medication. 
2. General clinical and epidemiological aspects 
The most severe psychiatric syndromes in endocrine diseases are not as frequent as in the 
past, due to improvements in diagnosis and treatment of the hormonal disorders (Kathol, 
2002). Still, a high prevalence of psychiatric disturbances has been reported in most 
endocrine conditions, including thyroid and parathyroid diseases. Depression and anxiety 
together with cognitive disorders are the most common presentations (Table 1). As 
expected, lifetime prevalence is even higher in several reports (Eiber et al. 1997). Cognitive 
impairment is rather frequent in conditions such as hyperparathyroidism, particularly 
among the elderly, and dementia can also be found; delirium, but also psychosis in clear 
consciousness, including paranoid psychosis and mania may be seen in severe endocrine 
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diseases. Methodological issues limit the value of the available data: case studies and case 
reports abound in this literature, research diagnostic criteria have rarely been used and 
comparison between studies is difficult due to wide differences in the samples selected and 
methods used. However, standardized research interviews were used in some studies 
reviewed here and standardized instruments in most. The emerging general picture 
suggests the clinical relevance of the documented psychopathology, including the 
depressive and anxiety syndromes, which may be very severe in diseases such as 
hyperthyroidism (Table 2). 
 
 Hyperthyroidism Hypothyroidism Hyperpara- 
thyroidism 
Hypopara- 
thyroidism 
Any Disorder 53%-100%  23%-66%  
Depression ++ 
30%-70% 
++ ++ 
16%-36% 
+ 
Apathy 
“Apathetic 
hyperthyroidism” + +  
Delirium + + 
++ 
2%-5% ++ 
Impaired 
cognition 
++ 
+++ 
 
Cretinism 
++ 
3%-12% 
+ 
Dementia Risk Factor 
DAT? 
++ + +/- 
Others 
 Overactivity 
 Irritability 
 Organic 
personality in 
the elderly 
 Slowing/Lethargy 
 Mania (Treatment 
induced) 
 Fatigue 
 Violent 
behaviour? 
 Social 
withdrawl 
 ”Neurotic” 
behaviour 
DAT: Dementia, Alzheimer Type.  
+/+++: Clinical relevance. 
Brown et al., 1987; Bunevicius et al.; Casella et al., 2008; Eiber et al., 1997; Espiritu et al., 2010; Joborn et 
al., 1986; Kathol & Delahunt, 1986; Mooradian, 2008; Pérez- Echeverria, 1985; Velasco et al., 1999; Solin 
et al., 2009  
Table 1. Psychiatric syndromes in thyroid and parathyroid disorders: prevalence and clinical 
relevance. 
It was in this context that we completed a study in 100 consecutive patients admitted to the 
Endocrine Unit in our University hospital (Pérez-Echeverría, 1985; Lobo et al., 1988). 
Patients hospitalized in the Internal Medicine ward were used as a comparison group, as 
well as outpatient groups of both the internal medicine and the endocrine Departments. 
Standardized instruments, including the Clinical Interview Schedule (CIS) and the General 
Health Questionnaire-28 items (GHQ-28), were used throughout the study. In support of the 
relevance of psychiatric syndromes in these patients and specifically in hyperthyroid 
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patients, the prevalence of disorder at the time of admission (first three days) was 
significantly higher than in all the comparison groups (Table 2). Similarly, according to 
standardized criteria, the severity of disorder was significantly higher in the endocrine 
inpatients (68% had “moderate” or “severe” syndromes) than in the control groups (26,6%, 
16% and 40%, respectively). 
 
Prevalence of any Disorder Comments 
Admission Discharge Severity of psychiatric 
disorders is 
significantly higher in 
endocrine in-patients 
(++); and decreases 
significantly at 
discharge (+++)  
All patients (n=100) 91% 54% 
Controls 
 I.M. in-patients (n=30) 
 I.M out-patients (n=100) 
 Endocrine out-patients 
(n=100)  
 
53,3% 
38% 
70% 
 
Hyperthyroidism 100% 86% 
Correlations 
biochemical variables 
(any)/ Irrtability, 
Psychastenia. 
+ Significance p< 0,05; ++ p<0,01; +++ p<0,001. 
* Pérez-Echeverría, 1985; Lobo et al., 1988. 
Table 2. Psychiatric disorders in endocrine in-patients and in hyperthyroidism in- patients. 
Prevalence and correlation with biochemical variables.* 
This epidemiological documentation may be important to identify the individuals at risk for 
specific psychiatric syndromes in liaison programs with endocrine departments; or to search 
for the syndromes when the psychiatrist consults in specific endocrine patients such as the 
individuals with thyroid or parathyroid conditions. Screening instruments such as the 
Hospital Anxiety and Depression Scale (HADS) (Lloyd et al., 2000) or the General Health 
Questionnaire-28 Items (Lobo et al., 1988) are considered to be appropriate in endocrine 
patients. The sections dedicated to specific endocrine diseases suggest when the search may 
be mandatory, such as in cases of hyperthyroidism, where anxiety, but also depressive 
syndromes may be severe or in cases of cognitive deficits in hypothyroid disease. Table 1 
also summarizes the authors’ judgement about the clinical relevance (+ to +++) of the 
psychiatric syndromes in these specific endocrine conditions, according to their frequency, 
severity and/or special characteristics. 
Non-biological hypotheses have been formulated to explain depressive or anxiety 
syndromes when there is considerable stress and psychosocial difficulties associated with 
conditions such as hyperthyroidism. However, the authors suggest that the “organic”, 
endocrine origin of the psychiatric syndromes in these patients is most important. The 
following data support this contention: studies documenting a higher prevalence of 
psychiatric disturbance than in comparable general population samples (Mayou et al., 1991) 
and, in particular, in medical samples of comparable severity of the medical disorder (Pérez-
Echeverría, 1985); both clinical practice and studies documenting that the prevalence of 
psychiatric disorder and/or its severity decreases after successful treatment of the endocrine 
condition (Pérez-Echeverría, 1985). Although some reports are discrepant (Joborn et al., 
1988), special support comes from studies documenting statistically significant correlations 
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between severity of psychiatric symptoms/syndromes and hormonal levels or biological 
parameters (Table 2) (Pérez-Echeverría, 1985; Lobo et al., 1988; Linder et al., 1988). 
In relation to diagnosis the dictum of experienced, anonymous liaison psychiatrists seem to 
be quite appropriate here: “In the general hospital, every psychiatric symptom is 
“organic”…unless you can document otherwise”. In taking the history of rather atypical 
psychiatric presentations, the clinical psychiatrist should include questions related to the 
thyroid or parathyroid disorder, particularly when there are signs and /or symptoms 
suggesting the endocrine abnormality (table 3). If the suggestions are well founded, he or 
she should also perform at least focal physical examinations to document the presence or 
absence of endocrine signs. In these cases, but not routinely, he or she should also indicate 
tests of endocrine function. 
Endocrinopathy Symptoms Signs 
Hyperthyroidism 
Diaphoresis 
Heat intolerance 
Oligomenorrhea 
Exophthalmos 
Tachycardia 
Arrytmia (in elderly) 
Tremor 
Hypothyroidism 
Cold intolerance 
Menorrhagia 
Goiter 
Slow relaxing reflexes 
Myxedema 
Hyperparathyroidism 
Nausea 
Muscular weakness 
(proximal) 
Abdominal pain 
Hypertension 
Hypoparathyroidism 
Muscle spams 
Paresthesias 
Choreiform movements 
Chvostek´s sign 
Trousseau´s sign 
Table 3. Somatic symptoms and signs suggesting a thyroid disease. 
According to the International Classification of Diseases (10th edition or ICD-10), the 
diagnosis of an “organic” psychiatric syndrome of thyroid or parathyroid origin in a given 
patient should be considered when the presenting syndrome is known to be associated with 
the specific endocrine disease, and is supported by the absence of suggestive evidence of an 
alternative cause of the mental syndrome. Specifically, the “organic” psychiatric syndrome 
in cases of thyroid or parathyroid disease is supported when: a) the psychiatric symptoms, 
the course of illness and/or the age of presentation are atypical for a primary psychiatric 
disorder; b) there is no family or personal history of the psychiatric condition; c) no 
precipitating stress is known; d) there is a temporal relationship between the onset of the 
psychiatric and the endocrine symptoms. The challenge for the consulting psychiatrist is to 
make explicit the diagnosis of the endocrine origin of the psychiatric syndrome early in the 
procedure, before his or her diagnosis is confirmed after observing that the syndrome 
disappears following the removal or improvement of the underlying endocrine disorder.  
Most psychiatric syndromes in endocrine patients resolve with standard treatment of the 
endocrine disease, and this applies to thyroid and parathyroid disorders. However, when 
symptoms are particularly severe or life-threatening; or when they last longer than 
reasonably expected (table 4), good clinical sense suggests the importance of psychiatric 
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treatment. Well-controlled studies are lacking, but syndrome specific medication is usually 
recommended, as well as supportive psychotherapy and, recently, cognitive-behavioural 
psychotherapy in cases of abnormal illness behaviour. Relevant clinical factors, and 
exceptions to these general norms will now be discussed for the specific endocrine diseases. 
Endocrinophaty Psychiatric syndromes 
Treat if psychiatric 
syndromes 
persist after adequate 
endocrine 
treatment* 
Hyperthyroidism Anxiety (Depression) 
 
>4 weeks 
or extreme severity 
 
Hypothyroidism Depression/ Anxiety >4 weeks 
Hyperparathyroidism  >4 weeks 
Hypoparathyroidism Depression ? 
*Treatment should also be recommended when syndromes are very severe or life threatening. 
Lobo et al., 2007.  
Table 4. Treatment of psychiatric syndromes with psychotropic medications in endocrine 
patients. 
3. Thyroid disease and the “clustering” of somatic and psychiatric morbidity  
In relation to epidemiology, we have recently studied the role of thyroid disease in the 
clustering of somatic and psychiatric morbidity in the elderly population. Pioneer studies by 
authors such as Eastwood and Trevelyan found that psychiatric and somatic illnesses tend to 
“cluster” in a limited group of individuals in the general population. The first author 
speculated about vulnerability to illness, and research in this area was considered “the main 
task for epidemiology in the field of psychosomatic medicine”. Since then, a considerable 
number of studies have approached this subject, and some authors argued that the association 
between somatic and psychiatric morbidity is well established. However, previous research 
was conducted primarily in clinical samples, and not in representative, general population 
samples (Scott et al., 2007). Furthermore, Eastwood’s statement (Eastwood, 1989) suggesting 
that the association of general psychiatric and somatic morbidity has not been convincingly 
shown in the elderly population is still valid. Given the relationships between comorbidity and 
frailty described in the elderly, as well as the negative consequences (Slaets, 2006), studies in 
the older population were considered to be a research priority.  
The study we conducted was part of the ZARADEMP Project, an epidemiological enquiry to 
document in the elderly community the prevalence, incidence and risk factors of dementia, 
depression and psychiatric morbidity, as well as their association with somatic morbidity 
(Lobo et al., 2005). The main objective in this specific study was to try to confirm in the 
elderly population the tendency of general psychiatric morbidity to cluster with general 
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somatic morbidity. In view of the considerable prevalence of thyroid disease in the elderly 
and the documented association between thyroid disturbances and psychopathology, we 
also set as an objective to study the role of thyroid disease in the clustering. 
The site of the study was Zaragoza, a capital concentrating 622,371 inhabitants (fifth city 
in Spain) or 51% the population of the historical kingdom of Aragón. The objectives and 
general methodology of the ZARADEMP Project have been previously described (Lobo et 
al., 2005). It is a longitudinal, epidemiological study with four waves, and Wave I 
(ZARADEMP I) was relevant for this report (Figure 1). It was the baseline, cross-sectional 
study, intended to document the prevalence and distribution of somatic and psychiatric 
morbidity and of comorbidity. Participating individuals have been followed up in Waves 
II, III and IV (or ZARADEMP II, III and IV) to eventually study the influence of 
hypothesized risk factors for incident cases. 
ZARADEMP Project
Design
ZARADEMP I
n = 4,803
Fase I: “Lay Interviewers”
Fase II: Specialists
ZARADEMP III
n = 3,160
Fase I: “Lay Interviewers”
Fase II: Specialists
Fase III: Hospital               
Background Study
“ ZARAGOZA 
Study”1990
ZARADEMP II
n = 4,061
Fase I: “Lay Interviewers”
Fase II: Specialists
Fase III: Hospital     
Prevalence
Incidence
Life-time risk
ZARADEMP IV
Year 2011.....
 
Fig. 1.  
A stratified, random sample of 4,803 individuals aged 55 and over was selected for the 
baseline study. The elderly were assessed with standardized, Spanish versions of 
instruments, including the Geriatric Mental State (GMS)-AGECAT (Lobo et al, 2005). The 
GMS is a semistructured standardized clinical interview used for assessing the mental 
state of elderly people. A computerized diagnostic program, AGECAT is available to be 
applied to it. This interview is also a syndrome case finding instrument, the GMS-B 
threshold scores discriminating between "non-cases", “subcases” and "cases". We also 
used the History and Aetiology Schedule (HAS), a standardized method of collecting history 
and etiology data from an informant, or directly from the respondent when he or she was 
judged to be reliable. Psychiatric cases were diagnosed according to GMS-AGECAT 
criteria, and somatic morbidity, and specifically thyroid disease was documented with the 
EURODEM Risk Factors Questionnaire. 
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 Cases (n) Prevalence (%) 95% CI 
55 – 64 years 
(n=1088) 
29 2,7 1.8 – 3,8 
65 – 74 years 
(n=1702) 
66 3,9 3.0 – 4,9 
75 – 84 years 
(n=1097) 
34 3,1 2.2 – 4,3 
≥85 years 21 2,3 1,4 – 3,5 
Table 5. Prevalence of thyroid disease in community-dwelling individuals aged ≥ 55 years 
(distribution by age group). 
The relevant results for this chapter may be summarized as follows. As expected, the 
prevalence of somatic disease tended to increase with age in most categories (Table 4). 
However, it decreased after the age of 84 in several categories, including thyroid disease. 
General comorbidity clustered in 19.9% of the elderly when hypertension was removed 
from the somatic conditions category, 33.5% of the sample remaining free of both somatic 
and psychiatric illness. General comorbidity was associated with age, female sex and 
limited education, but did not increase systematically with age. The frequency of 
psychiatric illness was higher among the somatic cases than among non-cases, and the 
frequency of somatic morbidity among the psychiatric cases was higher than among non-
cases. This association between somatic and psychiatric morbidity remained statistically 
significant after controlling for age, sex and education (OR= 1.61, IC 1.38-1.88). Most 
somatic categories were associated with psychiatric illness but, adjusting for demographic 
variables and individual somatic illnesses, the association remained statistically 
significant only for cerebro-vascular accidents, CVA’s (OR= 1,47, CI 1,09-1,98) and thyroid 
disease OR= 1,67, CI 1,10-2,54). 
 Without psychiatric morbidity (n=2211) 
Cases (n) Prevalence (%) 95% CI 
Thyroid disease 46 2,1 1,5 – 2,8 
 Psychiatric morbidity (n=2592) 
Thyroid disease Cases (n) Prevalence (%) 95% CI 
 104 4.0 3,3 – 4,8 
Table 6. Prevalence of thyroid disease in patients with or without psychiatric morbidity in 
community-dwelling individuals aged ≥ 55 years. 
This was the first study documenting in the (predominantly) elderly population that there is 
a positive and statistically significant association of general somatic and general psychiatric 
morbidity. Furthermore, in support of the initial hypothesis our results suggest that thyroid 
disease may have more weight in this association. 
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4. Hyperthyroidism  
Hyperthyroidism is usually accompanied by physiological symptoms such as sweating, heat 
intolerance and muscle weakness. However, also common symptoms such as nervousness, 
fatigue or weight lost may be confounded for primary psychiatric symptoms. Graves´ 
disease, an autosomal disorder, is the most frequent cause of hyperthyroidism or 
thyrotoxicosis. While proponents of psychosomatic theories suggested in the last century 
that an important etiological factor for hyperthyroidism was the presence of psychological 
conflicts, there is very slight evidence to support the theory. Clinicians in Europe, certainly 
do not support this conjecture, as shown in the E.C.L.W. study (Huyse et al, 2000). No 
cases of this endocrine condition were referred for psychiatric consult among 15,000 
medical inpatients seen in psychosomatic psychiatry services because of 
psychopathological reasons (Lobo et al , 1992). However, there is some evidence to 
support the idea that stress can precipitate the hyperthyroidism (Santos et al, 2002) or 
complicate the clinical course (Fukao et al , 2003 ). 
The study by Pérez- Echeverría was one of the early investigations reporting the prevalence 
of psychiatric disturbance among hyperthyroid patients. Only few more studies have 
reported prevalence data since then. (Trzepacz et al., 1988; Bunevicius et al., 2005). The 
study by Stern conducted in members of a patients` foundation documented, as expected, 
that anxiety (72%) and irritability (78%) were the commonest symptoms (Stern et al., 1996). 
Psychological disturbance of some degree is universal in Graves` disease (Pérez- 
Echeverría et al., 1986; Stern et al., 1996), and may delay the diagnosis of the hormonal 
disorder. Anxiety is most frequently reported, but also depressive syndromes. Rather 
unusual symptoms may accompany these psychopathological syndromes such as 
overactivity and restlessness or hyperacuity of perception and increased reaction to noise 
stimulus. It is the unusual presentation of anxiety (or depression) that may help the 
physician to differentiate the endocrine disorder from primary affective disturbance. 
Emotional lability may also be apparent, and both anxiety and irritability may be quite 
severe and stimulate relatively understandable behavior such as impatience and 
intolerance of frustration. While depression is not so common, it may be quite prominent 
and be accompanied by weakness, fatigue and other somatic symptoms. Psychomotor 
retardation is rare, the exception being the subgroup of elderly patients. “Apathetic 
hyperthyroidism” has been described in this age group (Mooradian & Arshg, 2008), and 
some of these cases may progress to stupor and coma. 
Classical studies suggested that up to 20% of Graves` disease patients might have some kind 
of psychosis. However, as discussed by Lishman , there was probably a selection bias 
(Lishman, 1998). Delirium-type, acute organic syndromes are now rare because of advances 
in medical treatment. However, delirium in such cases may be a medical emergency. 
Affective psychoses have been described (Brownlie et al., 2000; Marian et al, 2009), but also 
schizophrenia-type psychoses, most commonly with paranoid ideation. Organic personality 
disorder has been described, particularly among the apathetic elderly. Distraibility and 
over-arousal have also been reported, sometimes leading to persistent cognitive impairment, 
which may continue even after the patient is euthyroid (Stern et al, 1996). Specific cognitive 
difficulties in hyperthyroid patient have been described, such as deterioration of memory, 
concentration or visuomotor speed (MacCrimmon et al., 1979; Álvarez et al., 1983). 
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The possibility that subclinical hyperthyroidism in the elderly increases the risk of 
Alzheimer´s disease has been suggested (Kalmijn, 2001) and we are now involved in a large 
longitudinal study to assess specific risks of dementia, including thyroid disease, in a 15-
year follow-up study ingrained in the ZARADEMP project. (Lobo, 2005). 
The initial symptoms in hyperthyroidism may be quite similar to anxiety disorders, but 
the described, unusual symptoms of anxiety may alert the clinicians (Kathol et al., 1986 ). 
Other symptoms that should alert the physicians are the preference for cold and 
intolerance to heat, or loss of weight coupled with increased appetite. A careful medical 
history and examination are mandatory in such cases and the laboratory test would 
usually give unequivocal answers to the diagnostic difficulties. An accelerated pulse 
during sleep or cognitive difficulties are also considered to suggest the diagnosis of 
hyperthyroidism in such cases (Hall et al., 1979; Mackenzie,1988). To help in the 
differential diagnosis some specific scales have been developed (Iacovides et al, 2000). 
Transient thyroid hormone elevations, usually mild, may occur in approximately 10% of 
psychiatric inpatients, but should not be diagnosed of hyperthyroidism. Thyroid 
abnormalities have also been documented in some studies in primary affective disorders 
(Oomen et al., 1996). However, later studies did not replicate the findings (Engum et al., 
2002) and the possibility of factors of confusion such as the use of psychotropic 
medication has been considered. Other clinical situations may mimic the thyroid 
condition before the laboratory results are available, such as abuse of stimulants or drug 
intoxications. However, the nervousness and emotional lability in hyperthyroid patients 
may be wrongly diagnosed as alcohol abuse or abstinence. 
Subclinical hyperthyroidism has also stirred interest in recent studies. The clinical interest 
derives from the fact that it has been associated with cognitive deterioration and dementia 
in the elderly (Kalmijn,2000;Ceresini,2009), both in cross-sectional and longitudinal studies. 
While the clinical and epidemiological studies reviewed support the association of 
hyperthyroid function with psychopathological disturbance, the causal mechanisms are not 
clear (Bunevicius et al., 2006). One study suggested that the active thyroid hormone (T3) 
influenced mental performance in healthy subjects (Kathmann et al., 1994). The individuals 
overestimated time intervals and increased their word fluency, but no other cognitive 
problems were detected. Pérez-Echeverría (1985) and Lobo et al (1988) documented direct, 
convincing correlations between abnormal levels of thyroid hormones and 
psychopathology. The abnormal psychological phenomenon seemed to be directly related to 
the endocrine disturbance, since non-endocrine medical patients in the same ward, and with 
similar levels of illness severity had lower levels of psychopathology. Furthermore, in 
support of the direct effect of thyroid hormones elevation on the psychopathology, anxiety, 
depression and related phenomenon improved with “treatment as usual”, when hormonal 
levels returned to normal, at the time of hospital discharge. 
In general, there is a good resolution of anxiety and depression with antithyroid treatment 
alone, unless there is previous psychiatric history (Kathol et al., 1986). Beta-blockers such as 
propanolol are also considered to be effective in cases of anxiety (Trzepacz et al, 1988). 
However, recovery may be slow and reduced psychological well-being has been reported in a 
considerable proportion of “remitted” hyperthyroidism (Pérez-Echeverría, 1985). Bunevicius 
also reported persistent mood and anxiety symptoms in treated hyperthyroidism (Bunevicius 
et al., 2005). Psychosis may occur or be exacerbated by antithyroid medication. Low potency 
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neuroleptics such as haloperidol and perphenazine have been reported, including symptoms 
resembling thyroid storm and malignant neuroleptic syndrome. There is a limited clinical 
experience with the new generation of neuroleptics. Finally, treatment of depression is 
recommended if psychopathological symptoms are severe or persistent.  
5. Hypothyroidism  
Classical symptoms of hypothyroidism include fatigue and weakness, somnolence, weight 
gain, constipation and cold intolerance. However, other common symptoms may suggest 
primary psychiatric disease and include lethargy, progressive slowing, diminished initiative 
and impaired concentration and memory. (Kornstein et al., 2000). 
Congenital hypothyroidism is also well known, and usually occurs as the consequence of 
thyroid dysgenesis, and more rarely as the result of inherited defects in the synthesis of 
thyroid hormone. The cretinism syndrome emerges if hypothyroidism is untreated. This 
syndrome is characterized by mental retardation, aside from the classical somatic and 
neurological signs. Screening programs for hypothyroidism at birth are now mandatory to 
prevent this severe condition. (American Academy of Pediatrics, 2006), since early treatment 
should lead to normal intellectual development. The most frequent cause of adult 
hypothyroidism is Hashimoto´s thyroiditis or autoimmune thyroiditis. Treatment of Grave´s 
disease with radioactive iodine may also lead to hypothyroidism, but an important 
iatrogenic cause in psychiatric patients is the side effect of lithium, particularly in vulnerable 
individuals such as women or rapid cyclers. 
There are no good prevalence studies of psychiatric disturbance in hypothyroid patients, but 
the main psychiatric syndromes have been described in case reports and/or clinical 
samples. Depression and, to a lesser extent anxiety (Sait Gönen et al., 2004), occur rather 
frequently, even with moderate hormonal deficits, and could be observed as early as few 
weeks after the onset of the condition. Previous history of affective disorder is considered to 
increase the risk. The depressive syndromes may mimic primary affective disorder, 
particularly in old women, and may need the checking of hormonal levels for the 
differential diagnosis. The initial symptoms of hypothyroidism mimic the somatic 
symptoms of depression, and may include low energy, fatigue, apathy, low appetite and 
sleep disturbance. Marked irritability and labiliy of mood may alert to the presence of 
atypical syndromes, suggesting an organic condition. Thyroid replacement is required in 
such cases and is usually effective, although depression persists in a proportion of patients  
A special emphasis should be placed in subclinical hypothyroidism. In this controversial 
condition, which is sometimes classified as grade 2 and grade 3 hypothyroidism, there may 
be minimal clinical, traditional symptoms, and thyroid levels may be normal, but with 
increased TSH. The relevance of subclinical hypothyroidism is derived from the fact that 
depression is common and may severely affect quality of life. (Haggerty et al., 1993; 
Dermatini et al., 2010). In the study by Chueire et al. (2003), using standardized instruments 
and psychiatric diagnostic citeria, they found depression among 49% of subclinical 
hypothyroid, elderly patients. The same authors have recently reported that depression in 
such patients is more frequent than among patients with overt hyperthyroidism (Chueire et 
al., 2007). Furthermore, they conclude that subclinical hypothyroidism increases more than 
four times the risk of depression, and highlight the relevance of thyroid screening tests in 
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the elderly. Treatment of depression in such cases is recommended (Carvalho et al., 2009), 
but may be frustrating (Hendrick et al., 1998). It has been suggested that subclinical 
hypothyroidism is rather common in the general population, particularly in the adult and 
elderly women, but may go undetected and untreated. Screening tests of hormonal levels 
may be crucial in doubtful cases. 
Delirium has been observed in approximately 10% of severe cases of hypothyroidism, and 
organic delusional syndromes have been documented in some case reports. “Mixedema 
madness”, a psychosis in untreated cases of hypothyroidism was described before the 
standard use of thyroid function tests (Kudrjavcev, 1978), but is quite rare now. Some 
authors have called “Hashimoto`s encephalopathy” the clinical picture of delirium with 
focal neurological signs and seizures. It has been considered to be associated with high 
levels of serum antithyroid antibodies, but the psychopathological symptoms probably 
overlap with delirium of different etiologies (Schiess & Pardo, 2008). 
Longstanding hypothyroidism may end up in a marked dementia syndrome. Before, 
cognitive disturbance may be apparent (Samuels et al, 2008). Memory deterioration is 
common, but may be accompanied by impairment of other cognitive functions. While some 
cognitive difficulties may be associated with the depressive syndromes, some authors have 
reported independent, cognitive difficulties (Burmeister et al.,2001). Mild hypothyroidism 
has also been associated with mild cognitive difficulties (Bunevicius et al, 1999; Miller et al, 
2007). While most cases of cognitive disturbance improve with hormonal treatment, some 
studies reported negative results (Walsh et al., 2003). Hypothyroidism used to be considered 
one example of reversible dementia with appropriate hormonal treatment (Cummings et al., 
1980). However, most authors doubt about its effectiveness in well established cases of 
dementia (Clarnette & Patterson, 1994; Lobo et al., 2010). 
Present knowledge about the effects of thyroid hormones in the central nervous system 
suggests the critical influence in brain development, and probably a direct role in adult brain 
homeostasis. Multiple isolated effects have been described, including a modulation of 
noradrenergic, serotonergic, and dopaminergic receptor function, and an influence on second 
messenger, calcium homeostasis, axonal transport mechanisms, and morphology. However, 
both the biochemical mechanisms and the physiological relevance are poorly understood. 
Even minor changes in thyroid hormone may induce important affective changes (Bauer et 
al., 1990). However, the connections between this hormone and primary affective disorder 
remain controversial .Some authors conclude that depressed patients are basically euthyroid 
(Baumgartner, 1993). Thyroid autoimmunity has been reported in bipolar disorder (Kupka 
et al., 2002) but the finding needs replication. Special consideration merit the cases of 
hypothyroidism seen in 10% of patients treated with lithium. Disregulation in the 
hypothalamic-pituitary-thyroid axis is commonly linked to primary affective disorders 
(Hendrick, 1998; Engum et al., 2002). Close to 50% of depressive patients with major 
depression have a positive, blunted TSH response to TRH. While these findings support the 
connection between thyroid disorder and primary affective disorder (Stipcevic et al., 2008), 
other authors conclude that depressed patients are basically euthyroid (Baumgartner et al., 
1993). New studies are considered to be needed to clarify this relationship. 
The neuropsychiatric symptoms of hypothyroidism maybe the first to recover, probably in 
few days, with adequate hormonal replacement. Slow correction is usually recommended, 
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particularly in the elderly, because the risk of cardiac or psychiatric dysfunction. Short 
periods of mania or hypomania may occur during the treatment, but will typically subside 
during the replacement. Moderate doses of neuroleptics are usually well tolerated in cases 
of psychosis, but these cases may not recover totally.  
6. Hyperparathyroidism  
Primary hyperparathyroidism is often caused by parathyroid adenomas (Bresler et al., 
2002). It is characterized by the presence of elevated parathyroid hormone, elevated calcium 
and hypophosphatemia. Hyperparathyroidism may lead to renal calculus and bone disease. 
Classical symptoms of hypercalcemia, such as anorexia, lethargy or fatigue, may be 
attributed to primary psychiatric disease. The symptoms may be insidious, but gradually 
increase and may lead to coma. The early recognition of hyperparathyroidism is now more 
common, due to the use of routine biochemical screening. 
The prevalence of hyperparathyroidism is considered to be around 0.1%, and increases both 
in women and with age. Radiation of head and neck may produce this condition, but is also 
a known consequence of lithium therapy in psychiatric patients (Kingsbury & Salzman, 
1993). The common use of lithium in long term treatment of affective disorders should alert 
physicians about side effects, since hyperparathyroidism symptoms may be confounded for 
affective psychopathology. The determination of serum calcium levels may be considered in 
the protocol of atypical psychiatric presentations of cognitive difficulties or affective 
symptoms, particularly depression. Calcium levels may also be monitored in patients in 
lithium treatment, since hypercalcemia as a secondary affect has been reported and may be 
confounded with the relapse of affective symptoms (Pieri-Balandraud et al., 2001).The EEG 
is an important diagnostic tool in such cases, since the slow activity accompanied by frontal 
delta paroxysms are quite suggestive of hypercalcemia. 
Lithium is considered to alter the feedback inhibition, and the set point of the parathyroid 
gland. It also stimulates hormone secretion. The lower incidence of stones in lithium-induced 
hypercalcemia, contrary to what is observed in primary hyperparathyroidism, has been 
considered to be the effect of interference of lithium in cAMP production (Kingsburg et al 
1993). Hypercalcemia should be considered in the differential diagnosis of bipolar, lithium-
treated patients with unusual psychopathological symptoms and/or resistance to treatment. 
Mild calcium elevations may be managed medically. However, cessation of lithium frequently 
does not correct the hyperparathyrodism and the parathyroidectomy may be necessary. 
Psychopathological symptoms are considered to be quite common in hyperparathyroidism 
(Brown et al 1987). However, most studies are derived from case reports or were completed 
in short samples and standardized methods of assessment were rarely used (White et al 
1996). Depressive and anxiety syndromes have been most frequently described (Joborn et 
al., 1986; Birder, 1988). Nevertheless, the preponderance of symptoms such as apathy, 
fatigue, irritability or neuro-vegetative symptoms should alert the physician. Cognitive 
symptoms of depression are usually not as severe as in primary affective disorder, the 
exception being the elderly patients (Linder et al 1988). Overt delirium has frequently been 
observed when hypercalcemia is high (above 16 mg/dl), and coma has been reported with 
serum levels above 19 mg/dl (Petersen 1968). In the elderly, cognitive disorders and 
eventually dementing syndromes may occur if the endocrine disorder persists (Joborn et al., 
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1986). Psychosis has rarely been described, but Joborn et al reported paranoid ideas and 
hallucinations in their study and Bresler et al (2000) reported violent behavior, included 
attempted mass murder in a case of paranoid ideation in clear consciousness. More chronic 
cases, aside from cognitive disorder, have been associated with personality changes leading 
to withdrawn behavior and seclusion. 
The pathogenesis of psychiatric syndromes in hyperparathyroidism may be explained by the 
hipercalcemia itself, since similar symptoms have been reported in different etiologies. The 
calcium ions are considered to be crucial in normal neurotransmission. High calcium levels 
have been associated with abnormal CSF concentrations of monoamine metabolites, such as 
5-hydroxy-indoleacetic acid (5-HIAA) found in primary hyperparathyroid patients. Calcium 
levels correlated with depressive symptoms and returned to normal after parathyroid 
surgery (Joborn et al 1988). Affective symptoms in primary hyperparathyroidism have also 
been reported to correlate with abnormal levels of both cortisol and melatonin, which 
improve after successful surgery (Linder et al 1988). Nevertheless, other studies did not find 
a correlation of psychopathology and calcium levels. (Joborn et al 1988; White et al., 1996). 
The influence of hypomagnesemia and hypophosphoremia, as well as the parathormone 
itself and vitamin B have also been hypothesized to influence the pathogenesis of 
psychiatric symptoms in hyperparathyroidism. 
Most studies suggest that psychiatric symptoms in hyperparathyroidism significantly 
improve or disappear after successful surgical treatment, unless the endocrine disorder is 
chronic. (Roman and Sosa 2007, Casella et al., 2008, Espiritu, 2010). Joborn reported that 
improvement may be observed in few days, and the same authors have shown that 
approximately half the patients significantly improved in a follow-up period of several 
years (Joborn et al., 1988). Wilheim et al 2004 observed that both depression and quality of 
life improved in a similar proportion of patients. However, Chiang (Chiang et al .,2005), did 
not find significant differences in neuropsychological performance between patients 
undergoing parathyroidectomy and the controls. On the basis of significant improvement in 
depressive symptoms and quality of life in patients with mild hypercalcemia, 
parathyroidectomy has been suggested in the management of asymptomatic 
hyperparathyroidism (Wilheim et al., 2004). However, in view of rather conflicting results, 
we have previously recommended a conservative treatment in asymptomatic cases or cases 
with mild symptoms (Lobo et al.,1992).  
7. Hypoparathyroidism  
Hypoparathyroidism can occur as a primary form with inadequate parathyroid hormone 
secretion, but the commonest cause is the removal of, or interference with blood supply in the 
parathyroid gland during neck surgery. The affected patients present with hypocalcemia, 
which causes neuromuscular irritability. 
Muscle cramps and paresthesias are typical symptoms, but facial grimacing and seizures 
may occur, suggesting a neuro-psychiatric condition. In a classical study, Denko & Kaelbing 
(1962) and similarly other authors (Velasco et al., 1999), reported a high frequency of 
cognitive disorder, but a considerable proportion of patients had psychotic symptoms, 
including hallucinations and catatonic stupor. However, the systematic study of psychiatric 
symptoms in hyperparathyroid patients is sparse. Reviews of this subject have concluded 
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that approximately half the cases due to surgery had psychopathological symptoms, and the 
frequency might be even higher in idiopathic cases (Lishman 1998). Delirium has been 
commonly reported in the post-surgery period, as might be expected in relation to abrupt 
biochemical disturbances.  
In non-acute idiopathic hypoparathyroidism, emotional lability and anxious syndromes 
have been described, and also depressive syndromes. Cognitive difficulties and even 
dementia syndromes have also been reported in these patients. The emotional lability may 
coincide with fluctuating, neurotic kind of minor symptoms and behavior. Irritability, 
nervousness and socially inadequate behavior are among the symptoms most often 
described. On the contrary the reviews suggest that psychotic syndromes in clear 
conscientious are uncommon. Chronic cases of hypoparathyroidism may eventually lead to 
neurological and cognitive deficits. They are considered to be related to intracranial 
calcification, and in such cases they are irreversible (Kowdley et al., 1999). 
Hypoparathyroidism is also frequent in the velocardiofacial syndrome (22q.11.2 deletion 
syndrome), in wich attentional and behavioral disorders are common among children, and 
schizophreniform and bipolar disorders are common in adults. (Jolin et al., 2009). In the 
pathogenesis of this condition, the hypocalcemia itself is considered to be the main agent. 
Patients with calcium levels in the lower limit of normal may be relatively asymptomatic 
(“partial parathyroid insufficiency”), but psychopathological symptoms such as depression 
and anxiety may appear episodically, precipitated by calcium deprivation. In an early study, 
Fourman et al (1967) reported the efficacy of calcium versus placebo in a double blind 
clinical trial to improve the psychopathological symptoms. 
An important issue, similarly to other endocrine disorders, is the failure to detect and 
diagnose this condition. This is particularly relevant in cases of anxiety resistant to 
treatment. Since anxiety can provoke hyperventilation, tetany in hypoparathyroid patients 
may be precipitated (Fourman et al., 1967). In doubtful cases, calcium and phosphorus levels 
should be monitored, especially in patients operated in the neck. The presenting signs of 
hypoparathyroidism may be an epileptic crisis or an abnormal EEG. 
Psychiatric syndromes in non-chronic hypoparathyroidism patients are treatable with 
calcium supplements and vitamin D. (Velasco et al., 1999). Depressive and anxiety 
syndromes have a good response, unless they are severe. The benzodiazepines are 
considered to be effective in cases of anxiety. Improvement in cognitive syndromes has also 
been reported in a considerable proportion of patients, the exception being the severe cases 
and the dementia syndromes. There is some report about the susceptibility of these patients 
to the parkinsonian side effects of neuroleptics. However, Pratty et al (1986) did not confirm 
this unwanted side effect. 
8. Conclusions  
This chapter reviews available data in relation to the characteristics and frequency of 
psychiatric syndromes in primary thyroid and parathyroid disturbances, including the 
contributions of the authors. It also reviews issues of diagnosis and differential diagnosis; 
mechanisms of production of psychiatric symptomatology; and treatment issues, including 
response of psychiatric syndromes to treatment of the endocrinopathy and to psychotropic 
medication. The most severe psychiatric syndromes in endocrine diseases are not as 
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frequent as in the past, due to improvements in diagnosis and treatment of the hormonal 
disorders, but still, a high prevalence of psychiatric disturbances has been reported in both 
thyroid and parathyroid diseases. Depression and anxiety together with cognitive disorders 
are the most common presentations. Cognitive impairment is frequent among the elderly, 
and dementia can also be found; delirium, but also psychosis in clear consciousness, 
including paranoid psychosis and mania may be seen in severe endocrinopaties. 
Methodological issues limit the value of the available data. However, standardized research 
interviews were used in some studies reviewed here and standardized instruments in most. 
The emerging general picture suggests the clinical relevance of the documented 
psychopathology, which may be very severe in some cases. The authors review their 
contribution in two relevant, epidemiological type of studies. In the first one, neat 
correlations were documented between hormonal disturbances and psychopathology in 
patients hospitalized because of hyperthyroid conditions. In the second study, during the 
ZARADEMP project, the clustering of somatic and psychiatric morbidity was documented 
in a large, community sample of individuals aged 55 years or more, and thyroid disease was 
considered to have specific weight in this association.  
9. Acknowledgements  
Supported by Grants: 
 94-1562, 97-1321E, 98-0103, 01-0255, 03-0815, G03/128 from the Fondo de Investiugación 
Sanitaria, and the Spanish Ministry of Health, Instituto de Salud Carlos III. Madrid 
Spain. 
 CIBERSAM PI10/01132 from the Instituto de Salud Carlos III 
10. References 
Alvarez Ma, Gomez A, Alavez E, et al: Attention disturbance in Grave´s disease. 
Psychoneuroendocrinology 8:451-454,1983 
American Academy of Pediatrics, Section on Endocrinology an Committee on Genetics: 
Update of newborn screening and therapy for congenital hytpothyroidism. 
Pediatrics 117:2290-2303,2006 
Bauer, M.S. and Whybrow, P.C. (1990). Rapid cycling bipolar affective disorder. II. 
Treatment of refractory rapid cycling with high-dose levothyroxine: a preliminary 
study. Arch Gen Psychiatry. 47, 435-440. 
Baumgartner, A. (1993). Thyroid hormones and depressive disorders--critical overview and 
perspectives. Part 1: Clinical aspects. Nervenarzt. 64, 1-10. 
Bresler, S.A., Logan, W.S. and Washington, D. (2000). Hyperparathyroidism and psychosis: 
possible prelude to murder. J Forensic Sci. 45, 728-730. 
Brown, G.G., Preisman, R.C. and Kleerekoper, M. (1987). Neurobehavioral symptoms in 
mild primary hyperparathyroidism: related to hypercalcemia but not improved by 
parathyroidectomy. Henry Ford Hosp Med J. 35, 211-215. 
Brownlie, BE., Rae, AM., Walshe, JW.,et al: Psychoses association-thytoxicosis-"thytotoxic 
psychosis": a report of with statistical analysis of incidence. Eur J End 142:438-
444,2000 
www.intechopen.com
 Thyroid and Parathyroid Diseases – New Insights into Some Old and Some New Issues 254 
Bunevicius R, Prange AJ, Jr. Psychiatric manifestations of Graves' hyperthyroidism: 
pathophysiology and treatment options. CNS Drugs2006;20(11):897-909. 
Burmeister LA, Ganguli M, Dodge HH, Toczek T, DeKosky ST, Nebes RD. Hypothyroidism 
and cognition: preliminary evidence for a specific defect in memory. Thyroid2001 
Dec;11(12):1177-85. 
Carroll, B.J., Feinberg, M., Greden, J.F., Tarika, J., Albala, A.A., Haskett, R.F., James, N.M., 
Kronfol, Z., Lohr, N., Steiner, M., de Vigne, J.P. and Young, E. (1981). A specific 
laboratory test for the diagnosis of melancholia. Standardization, validation, and 
clinical utility. Arch Gen Psychiatry. 38, 15-22. 
Carvalho GA, Bahls SC, Boeving A, Graf H. Effects of selective serotonin reuptake inhibitors 
on thyroid function in depressed patients with primary hypothyroidism or normal 
thyroid function. Thyroid2009 Jul;19(7):691-7. 
Casella C, Pata G, Di Betta E, Nascimbeni R. [Neurological and psychiatric disorders in 
primary hyperparathyroidism: the role of parathyroidectomy]. Ann Ital Chir2008 
May-Jun;79(3):157-61; discussion 61-3. 
Ceresini G, Lauretani F, Maggio M, Ceda GP, Morganti S, Usberti E, et al. Thyroid function 
abnormalities and cognitive impairment in elderly people: results of the 
Invecchiare in Chianti study. J Am Geriatr Soc2009 Jan;57(1):89-93. 
Chiang, C. Y., D. G. Andrewes, D. Anderson, M. Devere, I. Schweitzer and J. D. Zajac. 2005. 
"A controlled, prospective study of neuropsychological outcomes post 
parathyroidectomy in primary hyperparathyroid patients." Clin Endocrinol (Oxf) 
62(1):99-104. 
Chueire VB, Romaldini JH, Ward LS. Subclinical hypothyroidism increases the risk for 
depression in the elderly. Arch Gerontol Geriatr. 2007 Jan-Feb;44 (1):21-8.  
Chueire VB, Silva ET, Perotta E, Romaldini JH, Ward LS. High serum TSH levels are 
associated with depression in the elderly. Arch Gerontol Geriatr. 2003 May-
Jun;36(3):281-8. 
Clarnette RM, Patterson CJ. Hypothyroidism: does treatment cure dementia? J Geriatr 
Psychiatry Neurol1994 Jan-Mar;7(1):23-7. 
Cummings, J., D. F. Benson and S. LoVerme, Jr. 1980. "Reversible dementia. Illustrative 
cases, definition, and review." JAMA 243(23):2434-2439. 
Demartini, B., Masu, A., Scarone, S., Pontiroli, AE., & Gambini, O. Prevalence of depression 
in patients affected by subclinical hypothyroidism. Panminerva Med Dec;52(4):277-
82. 
Denko, J. D. and R. Kaelbling. 1962. "The psychiatric aspects of hypoparathyroidism." Acta 
Psychiatr Scand Suppl 38(164):1-70. 
Eastwood R. Relationship between physical and psychological morbidity. In: Williams P, 
Wilkinson G, Rawnsley, K. editors The scope of epidemiological psuchiatry. 
London: Routledge, 1989. pp.210-21 
Eiber, R., Berlin, I., Grimaldi, A. and Bisserbe, J.C. (1997). Insulin-dependent diabetes and 
psychiatric pathology: general clinical and epidemiologic review. Encephale. 23, 351-
357. 
Engum, A., Bjoro, T., Mykletun, A. and Dahl, A.A. (2002). An association between 
depression, anxiety and thyroid function--a clinical fact or an artefact? Acta 
Psychiatr Scand. 106, 27-34. 
www.intechopen.com
 Thyroid and Parathyroid Diseases and Psychiatric Disturbance 255 
Espiritu RP, Kearns AE, Vickers KS, Grant C, Ryu E, Wermers RA. Depression in Primary 
Hyperparathyroidism: Prevalence and Benefit of Surgery. J Clin Endocrinol Metab 
Sep 14. 
Fourman, P., Rawnsley, K., Davis, R.H., Jones, K.H. and Morgan, D.B. (1967). Effect of 
calcium on mental symptoms in partial parathyroid insufficiency. Lancet. 2, 914-
915. 
Fukao A, Takamatsu J, Murakami Y, Sakane S, Miyauchi A, Kuma K, et al.(2003) The 
relationship of psychological factors to the prognosis of hyperthyroidism in 
antithyroid drug-treated patients with Graves' disease. Clin Endocrinol (Oxf)2003 
May;58(5):550-5. 
Haggerty JJ, Jr., Stern RA, Mason GA, Beckwith J, Morey CE, Prange AJ, Jr. Subclinical 
hypothyroidism: a modifiable risk factor for depression? Am J Psychiatry1993 
Mar;150(3):508-10. 
Hall RC, Gruzenski WP, Popkin MK. Differential diagnosis of somatopsychic disorders. 
Psychosomatics1979 Jun;20(6):381-5, 8-9. 
Hendrick V, Altshuler L, Whybrow P. Psychoneuroendocrinology of mood disorders. The 
hypothalamic-pituitary-thyroid axis. Psychiatr Clin North Am1998 Jun;21(2):277-
92. 
Huyse FJ, Herzog T, Lobo A, Malt UF, Opmeer BC, Stein B, Creed F, Crespo MD, Cardoso 
G, Guimaraes-Lopes R, Mayou R, van Moffaert M, Rigatelli M, Sakkas P, Tienari P. 
European Consultation Liaison Psychiatric Services: the ECLW collaborative study. 
Acta Psychiatrica Scandinavica 2000; 101(5): 360-366. 
Iacovides A, Fountoulakis KN, Grammaticos P, Ierodiakonou C. Difference in symptom 
profile between generalized anxiety disorder and anxiety secondary to 
hyperthyroidism. Int J Psychiatry Med2000;30(1):71-81. 
Joborn, C., Hetta, J., Palmer, M., Akerstrom, G. and Ljunghall, S. (1986). Psychiatric 
symptomatology in patients with primary hyperparathyroidism. Ups J Med Sci. 91, 
77-87. 
Joborn, C., Hetta, J., Rastad, J., Agren, H., Akerstrom, G. and Ljunghall, S. (1988). Psychiatric 
symptoms and cerebrospinal fluid monoamine metabolites in primary 
hyperparathyroidism. Biol Psychiatry. 23, 149-158. 
Jolin, E. M., R. A. Weller and E. B. Weller. 2009. "Psychosis in children with velocardiofacial 
syndrome (22q11.2 deletion syndrome)." Curr Psychiatry Rep 11(2):99-105. 
Kalmijn, S., Mehta, K.M., Pols, H.A., Hofman, A., Drexhage, H.A. and Breteler, M.M. (2000). 
Subclinical hyperthyroidism and the risk of dementia. The Rotterdam study. Clin 
Endocrinol (Oxf). 53, 733-737. 
Kathmann N, Kuisle U, Bommer M, Naber D, Muller OA, Engel RR. Effects of elevated 
triiodothyronine on cognitive performance and mood in healthy subjects. 
Neuropsychobiology1994;29(3):136-42. 
Kathol R.G. (2002). Endocrine Disorders. In The American Psychiatric Publishing textbook of 
consultation-liaison psychiatry psychiatry in the medically ill, ed., M.G. Wise and J.R. 
Rundell, 2nd edn, pp. 563-567. Washington, DC: American Psychiatric Pub. 
Kathol, R.G. and Delahunt, J.W. (1986). The relationship of anxiety and depression to 
symptoms of hyperthyroidism using operational criteria. Gen Hosp Psychiatry. 8, 23-
28. 
www.intechopen.com
 Thyroid and Parathyroid Diseases – New Insights into Some Old and Some New Issues 256 
Kathol, R.G., Turner, R. and Delahunt, J. (1986). Depression and anxiety associated with 
hyperthyroidism: response to antithyroid therapy. Psychosomatics 27, 501-505. 
Kingsbury SJ, Salzman C. Lithium's role in hyperparathyroidism and hypercalcemia. Hosp 
Community Psychiatry1993 Nov;44(11):1047-8. 
Kowdley, K. V., B. M. Coull and E. S. Orwoll. 1999. "Cognitive impairment and intracranial 
calcification in chronic hypoparathyroidism." Am J Med Sci 317(5):273-277. 
Kornstein SG, Sholar EF, Gardner DG: Endocrine disorders, in Psychiatric Care of the 
Medical Patient, 2nd Edition. Edited by Stoudemire A, Fogel BS, Grennberg D. New 
York, Oxford University Press,2000, pp 801-819 
Kupka, R.W., Nolen, W.A., Post, R.M., McElroy, S.L., Altshuler, L.L., Denicoff, K.D., 
Frye.M.A.,Keck, P.E. Jr, Leverich, G.S., Rush, A.J., Suppes, T., Pollio, C. and 
Drexhage, H.A. (2002). High rate of autoimmune thyroiditis in bipolar disorder: 
lack of association with lithium exposure. Biol Psychiatry. 51, 305-311. 
Kudrjavcev T. Neurologic complications of thyroid dysfunction. Adv Neurol1978;19:619-36. 
Linder, J., Brimar, K., Granberg, P.O., Wetterberg, L. and Werner, S. (1988). Characteristic 
changes in psychiatric symptoms, cortisol and melatonin but not prolactin in 
primary hyperparathyroidism. Acta Psychiatr Scand. 78, 32-40. 
Lishman´s, W.A. (2009). Endocrine diseases and metabolic disorders. In Organic Psychiatry, 
4th edn. Wiley-Blackwell. 
Lishman, W.A. (1998). Endocrine Diseases and Metabolic Disorders. In Organic psychiatry the 
psychological consequences of cerebral disorder , 3rd edn, pp. 507-69. Oxford: Blackwell 
Science. 
Lloyd, C.E., Dyer, P.H. and Barnett, A.H. (2000). Prevalence of symptoms of depression and 
anxiety in a diabetes clinic population. Diabet Med. 17, 198-202. 
Lobo, A, Campos R, Marcos G, García-Campayo J, Campayo A, Lopez-Antón R & Pérez-
Echeverría MJ.(2007). Somatic and psychiatric co-morbidity in Primary Care 
patients in Spain. Eur J Psychiat 2007; 21(1): 71-8. 
Lobo, A., Saz, P., Marcos G, Dia JL, De-la-Camara, C., & Ventura T. Prevalence of dementia 
in a southern European population in two different time periods: the ZARADEMP 
Project. Acta Psychiatr Scand2007 Oct;116(4):299-307. 
Lobo, A., Saz, P. Marcos, C. Día, JL. De la Cámara, C. Ventura, T. (2005). The ZARADEMP 
Project on the Incidence, Prevalence and Risk Factors of Dementia (and Depression) 
in the Elderly Community: ll. Methods an First Results. Eur J Psychiatry 2005;19-40-
54 
Lobo, A, Huyse, F., Herzog, T., Malt, V.F. and E.C.L.W. (1992). Profiles of psychiatric and 
physical co-morbidity. Paper read before the E.C.L.W. Health Service Study 
Conference: Amsterdam 
Lobo, A., Perez-Echeverria, M.J., Jimenez-Aznarez, A. and Sancho, M.A. (1988). Emotional 
disturbances in endocrine patients. Validity of the scaled version of the General 
Health Questionnaire (GHQ-28). Br J Psychiatry. 152, 807-812. 
Lobo-Escolar A, Saz P, Marcos G, Quintanilla MA, Campayo A, Lobo A. Somatic and 
psychiatric comorbidity in the general elderly population: results from the 
ZARADEMP Project. J Psychosom Res2008 Oct;65(4):347-55. 
Lobo A, Saz P, Quintanilla MA. Dementia. In: Levenson JL, editor. Textbook of 
Psychosomatic Medicine. Washington: American Psychiatric Press (2010, in press) 
www.intechopen.com
 Thyroid and Parathyroid Diseases and Psychiatric Disturbance 257 
MacCrimmon DJ, Wallace JE, Goldberg WM, et al: Emotional disturbance and cognitive 
deficits in hyperthyroidism. Psychosom Med 41:331-340, 1979 
Mackenzie AH. Differential diagnosis of rheumatoid arthritis. Am J Med1988 Oct 
14;85(4A):2-11. 
Marian G, Nica EA, Ionescu BE, Ghinea D. Hyperthyroidism--cause of depression and 
psychosis: a case report. J Med Life2009 Oct-Dec;2(4):440-2. 
Mayou, R., Peveler, R., Davies, B., Mann, J. and Fairburn, C. (1991). Psychiatric morbidity in 
young adults with insulin-dependent diabetes mellitus. Psychol Med. 21, 639-645. 
Miller KJ, Parsons TD, Whybrow PC, Van Herle K, Rasgon N, Van Herle A, et al.(2007) 
Verbal memory retrieval deficits associated with untreated hypothyroidism. J 
Neuropsychiatry Clin Neurosci2007 Spring;19(2):132-6. 
Miller KJ, Parsons TD, Whybrow PC, van Herle K, Rasgon N, van Herle A, et al. Memory 
improvement with treatment of hypothyroidism. Int J Neurosci2006 
Aug;116(8):895-906. 
Mooradian AD. Asymptomatic hyperthyroidism in older adults: is it a distinct clinical and 
laboratory entity? Drugs Aging2008;25(5):371-80. 
Oomen, H.A., Schipperijn, A.J. and Drexhage, H.A. (1996). The prevalence of affective 
disorder and in particular of a rapid cycling of bipolar disorder in patients with 
abnormal thyroid function tests. Clin Endocrinol (Oxf). 45, 215-223. 
Pérez-Echeverría, M.J. (1985). Correlaciones entre trastornos endocrinológicos, niveles 
hormonales en sangre, variables de personalidad y alteraciones psicopatológicas. 
Doctoral Thesis, Universidad de Zaragoza. 
Petersen, P. (1968). Psychiatric disorders in primary hyperparathyroidism. J Clin Endocrinol 
Metab. 28, 1491-1495. 
Pieri-Balandraud N, Hugueny P, Henry JF, Tournebise H, Dupont C. [Hyperparathyroidism 
induced by lithium. A new case]. Rev Med Interne2001 May;22(5):460-4 
Pratty, J.S. , Ananth, J. and O'Brien, J.E. (1986). Relationship between dystonia and serum 
calcium levels. J Clin Psychiatry. 47, 418-419. 
Roman S, Sosa JA. Psychiatric and cognitive aspects of primary hyperparathyroidism. Curr 
Opin Oncol2007 Jan;19(1):1-5. 
Sait Gönen M, Kisakol G, Savas Cilli A, Dikbas O, Gungor K, Inal A, et al. Assessment of 
anxiety in subclinical thyroid disorders. Endocr J2004 Jun;51(3):311-5. 
Samuels MH. Cognitive function in untreated hypothyroidism and hyperthyroidism. Curr 
Opin Endocrinol Diabetes Obes2008 Oct;15(5):429-33. 
Santos AM, Nobre EL, Garcia e acosta:Graves´s disease and stress.ActaMed Port 15:423-
427,2002 
Schiess N, Pardo CA: Hashimoto´s encephalopathy. Ann New York academy Science 
1142:254-265, 2008. 
Scott KM, Bruffaerts R, Tsang A, Ormel J, Alonso J, Angermeyer MC, et al.(2007) 
Depression-anxiety relationships with chronic physical conditions: results from the 
World Mental Health Surveys. J Affect Disord2007 Nov;103(1-3):113-20. 
Slaets JP. Vulnerability in the elderly: frailty. Med Clin North Am2006 Jul;90(4):593-601. 
Stern RA, Robinson B, Thorner AR, et al: A survery study of neuropsychiatric complaints in 
patients with Grave´s disease. J Neupsychiatry Clin Neurosci 8:181,1996 
Stipcevic T, Pivac N, Kozaric-Kovacic D, Muck-Seler D. Thyroid activity in patients with 
major depression. Coll Antropol2008 Sep;32(3):973-6. 
www.intechopen.com
 Thyroid and Parathyroid Diseases – New Insights into Some Old and Some New Issues 258 
Trzepacz, P.T., McCue, M., Klein, I., Levey, G.S. and Greenhouse, J. (1988). A psychiatric and 
neuropsychological study of patients with untreated Graves' disease. Gen Hosp 
Psychiatry. 10, 49-55. 
Velasco PJ, Manshadi M, Breen K, Lippmann S. Psychiatric aspects of parathyroid disease. 
Psychosomatics1999 Nov-Dec;40(6):486-90. 
Walsh JP, Shiels L, Lim EM, Bhagat CI, Ward LC, Stuckey BG, et al. Combined 
thyroxine/liothyronine treatment does not improve well-being, quality of life, or 
cognitive function compared to thyroxine alone: a randomized controlled trial in 
patients with primary hypothyroidism. J Clin Endocrinol Metab2003 
Oct;88(10):4543-50. 
White, R.E., Pickering, A. and Spathis, G.S. (1996). Mood disorder and chronic 
hypercalcemia. J Psychosom Res. 41, 343-347. 
Wilhelm SM, Lee J, Prinz RA. Major depression due to primary hyperparathyroidism: a 
frequent and correctable disorder. Am Surg2004 Feb;70(2):175-9; discussion 9-80. 
www.intechopen.com
Thyroid and Parathyroid Diseases - New Insights into Some Old
and Some New Issues
Edited by Dr. Laura Ward
ISBN 978-953-51-0221-2
Hard cover, 318 pages
Publisher InTech
Published online 07, March, 2012
Published in print edition March, 2012
InTech Europe
University Campus STeP Ri 
Slavka Krautzeka 83/A 
51000 Rijeka, Croatia 
Phone: +385 (51) 770 447 
Fax: +385 (51) 686 166
www.intechopen.com
InTech China
Unit 405, Office Block, Hotel Equatorial Shanghai 
No.65, Yan An Road (West), Shanghai, 200040, China 
Phone: +86-21-62489820 
Fax: +86-21-62489821
This book was designed to meet the requirements of all who wish to acquire profound knowledge of basic,
clinical, psychiatric and laboratory concepts as well as surgical techniques regarding thyroid and parathyroid
glands. It was divided into three main sections: 1. Evaluating the Thyroid Gland and its Diseases includes basic
and clinical information on the most novel and quivering issues in the area. 2. Psychiatric Disturbances
Associated to Thyroid Diseases addresses common psychiatric disturbances commonly encountered in the
clinical practice. 3. Treatment of Thyroid and Parathyroid Diseases discusses the management of thyroid and
parathyroid diseases including new technologies.
How to reference
In order to correctly reference this scholarly work, feel free to copy and paste the following:
A. Lobo-Escolar, A. Campayo, C.H. Gómez-Biel and A. Lobo (2012). Thyroid and Parathyroid Diseases and
Psychiatric Disturbance, Thyroid and Parathyroid Diseases - New Insights into Some Old and Some New
Issues, Dr. Laura Ward (Ed.), ISBN: 978-953-51-0221-2, InTech, Available from:
http://www.intechopen.com/books/thyroid-and-parathyroid-diseases-new-insights-into-some-old-and-some-
new-issues/thyroid-disease-and-psychiatric-disturbance
© 2012 The Author(s). Licensee IntechOpen. This is an open access article
distributed under the terms of the Creative Commons Attribution 3.0
License, which permits unrestricted use, distribution, and reproduction in
any medium, provided the original work is properly cited.
